Author:
Katte Jean-Claude,Penanje Kiya,Agoons Batakeh B.,Djahmeni Eric Noel,Mbacham-Ngwafor Sharon,Moor Vicky Jocelyne Ama,Koki Paul,Mbacham Wilfred
Abstract
Abstract
Background
Procalcitonin is an inflammatory marker strongly associated with the presence of bacterial infection. It has been considered raised in severe malaria infection as opposed to uncomplicated malaria. There are suggestions that it may be raised only when there is concomitant unnoticeable bacterial infection during a malaria crisis. We aimed to assess the difference in plasma procalcitonin levels between children affected by severe and uncomplicated malaria.
Methods
We assessed plasma procalcitonin levels in 83 children diagnosed with malaria with no clinical and biological evidence of concomitant bacterial infection. Severity of malaria was established using WHO guidelines. Procalcitonin was determined using the ELISA method. Non-parametric Mann-Whitney U test was used to compare medians across the 2 groups. Statistical significance was set for all p values < 0.05.
Results
Of the 83 participants, 28 had uncomplicated malaria, and 55 had severe malaria. PCT levels were obtained in 24 and 40 subjects of each group, respectively, and were similar in both groups; [2.76 (2.52–2.93) vs 2.74 (2.52–2.98) ng/ml, p = 0.916]. The parasite density was lower in the uncomplicated malaria group than in the severe malaria group, but not statistically significant; [22,192 (9110–44 654) vs 31 684 (13 960–73 500) parasites/μl, p = 0.178]. There was no correlation between the parasite density in the general study population and PCT levels (r = 0.072, p = 0.572).
Conclusion
In the absence of overt bacterial infection, procalcitonin levels are not different between children affected with uncomplicated malaria and those with severe malaria. Therefore, bacterial infection should be thoroughly checked for in children with raised serum procalcitonin diagnosed with severe malaria.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference25 articles.
1. Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55(5):651–62. https://doi.org/10.1093/cid/cis464.
2. Cleland DA, Eranki AP. Procalcitonin. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
3. Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care. 2007;11(3):R60. https://doi.org/10.1186/cc5926.
4. Snow RW, Korenromp EL, Gouws E. Pediatric Mortality in Africa: Plasmodium falciparum Malaria as a Cause or Risk? The Intolerable Burden of Malaria II: What’s New, What’s Needed: Supplement to Volume 71(2) of the American Journal of Tropical Medicine and Hygiene. American Society of Tropical Medicine and Hygiene. 2004.
5. Fact sheet about Malaria. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria. Accessed 13 Dec 2020.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献